Merck · 1 day ago
Senior Principal Scientist, Upstream Process R&D
Merck is a company dedicated to delivering medical breakthroughs through innovative science and technology. They are seeking a Senior Principal Scientist to lead upstream bioprocessing initiatives and collaborate with teams to develop robust manufacturing processes for biologics.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Serve as a scientific leader to shape and drive innovation across the Biologics pipeline, strategy, and science
Anticipate and solve scientific and technical challenges across projects and functional teams, in a fast-paced, multidisciplinary environment
Lead the development of robust and scalable upstream processes for biologics in various stages of clinical development, as well as process characterization and regulatory filings for successful commercialization
Improve upstream processes by increasing efficiency and cost-effectiveness through research and innovation, while evaluating technologies and industry best practices
Collaborate with academia, industry, and vendors to facilitate the development and early adoption of novel process technologies
Contribute to strategic initiatives; work with senior leaders to establish overall project strategy and guide teams in its execution
Conceptualize, plan, and execute projects using effective organizational, prioritization, and problem-solving skills
Stay updated on the scientific and regulatory landscape; contribute scientifically and build your reputation through conference participation
Represent BPR&D as a upstream bioprocess expert/co-leader in internal and cross-functional project teams
Supervise, coach, and develop talent within the functional area; guide career development; build strong, collaborative teams
Champion compliance and safety while promoting a culture of diversity, equity, and inclusion
Qualification
Required
Ph.D. with 10+ years, MS with 12+ years, or BS with 14+ years of industry experience in Chemical/Biochemical Engineering or a related field
Strong fundamental knowledge and subject matter expertise in cell-culture process development for biologics, fed-batch cell culture, bioreactor scale-up and scale-down, as well as recent advances, and challenges in the field
Expertise in independently conducting and directing the design, execution, analysis, and documentation of all stages of cell-culture process development
Track record of accomplishments in upstream bioprocessing with a history of peer-reviewed publications and presentations. Strong understanding of cell metabolism and biochemical pathways relevant to bioprocessing
Knowledge of biologics CMC development
Ability to adapt to and prioritize complex objectives under tight timelines in a rapidly changing environment
Experience leading internal and external cross-functional, matrixed teams
Demonstrated scientific leadership with significant, measurable project impacts across a diverse set of programs
Action-oriented mindset with a capacity for creativity; ability to take initiative, innovate, iterate, and solve problems
Supervise, coach and mentor scientists to maximize talent development and utilization
Excellent interpersonal and communication skills
Preferred
Leadership of CMC development teams
Experience with continuous biomanufacturing integrated with process-analytical technologies
Intensified inoculum and perfusion process development
Expertise in media/solution development and chemistry
High-throughput experimentation, automation, and process control
Knowledge of microbial fermentation
Cell culture predictive modeling (omics (transcriptomics, metabolomics, or/and proteomics), metabolic flux analysis); statistics, data-science, machine learning, artificial intelligence
Benefits
Medical
Dental
Vision healthcare
Other insurance benefits (for employee and family)
Retirement benefits, including 401(k)
Paid holidays
Vacation
Compassionate and sick days
Company
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Funding
Current Stage
Public CompanyTotal Funding
$5.59MKey Investors
Private Capital AdvisorsGavi, the Vaccine Alliance
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO
Leadership Team
Recent News
2026-01-08
2026-01-08
2026-01-08
Company data provided by crunchbase